Oclacitinib
Properties
- Molecular formula
- C15H23N5O2S
- Molar mass
- 337.44 g/mol
- Exact mass
- 337.1572 Da
- logP
- 1.50Crippen estimate
- Polar surface area
- 91.0 Ų
- H-bond donors / acceptors
- 2 / 5
- Rotatable bonds
- 5
Hazards
No GHS classification is on file for this compound. That is not evidence that it is harmless.
Identifiers
CAS number
1208319-26-9SMILES
CNS(=O)(=O)CC1CCC(CC1)N(C)C2=NC=NC3=C2C=CN3InChIKey
HJWLJNBZVZDLAQ-UHFFFAOYSA-NInChI
InChI=1S/C15H23N5O2S/c1-16-23(21,22)9-11-3-5-12(6-4-11)20(2)15-13-7-8-17-14(13)18-10-19-15/h7-8,10-12,16H,3-6,9H2,1-2H3,(H,17,18,19)Weigh it out
Type any one amount. The others follow from the molar mass.
Work with Oclacitinib
Stereoisomers, salts and isotopologues
The same compound in another form: other stereochemistry, a salt or hydrate, the free acid or base, or an isotope-labelled version.
Similar compounds
N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine477600-74-148 % similar
N-Methyl-N-((3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine477600-73-041 % similar
Epitofacitinib, (3R,4S)-1092578-46-540 % similar
(3S,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile1092578-48-740 % similar
Tofacitinib477600-75-240 % similar
2-(7H-Pyrrolo[2,3-D]pyrimidin-4-yl)isoindoline-1,3-dione741686-49-735 % similar
Capivasertib1143532-39-135 % similar
Tofacitinib citrate540737-29-933 % similar
Tanimoto similarity of circular fingerprints over the whole catalogue.